Literature DB >> 21561513

Making the case for talking to patients about the costs of end-of-life care.

Greer Donley1, Marion Danis.   

Abstract

Costs at the end of life disproportionately contribute to health care costs in the United States. Addressing these costs will therefore be an important component in making the U.S. health care system more financially sustainable. In this paper, we explore the moral justifications for having discussions of end-of-life costs in the doctor-patient encounter as part of an effort to control costs. As health care costs are partly shared through pooled resources, such as insurance and taxation, and partly borne by individuals through out-of-pocket expenses, we separate our defense for, and approach to, discussing both pooled and individual aspects of cost. We argue that there needs to be a shift away from formulating the options as a dichotomous choice of paying attention to end-of-life costs versus ignoring such costs. The question should be how personal costs will be managed and how societal expenditures should be allocated. These are issues that we believe patients care about and need to have addressed in a manner with which they are comfortable. Conversations about how money will be spent at the end of life should begin before the end is near. We propose discussing costs from the onset of chronic illness and incorporating financial issues in advance care planning. Through these approaches one can avoid abruptly and insensitively introducing financial issues at the very conclusion of a person's life when one would prefer to address the painful and important issues of spiritual and existential loss that are appropriately the focus when a person is dying.
© 2011 American Society of Law, Medicine & Ethics, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21561513      PMCID: PMC3635951          DOI: 10.1111/j.1748-720X.2011.00587.x

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  37 in total

1.  Discussing health care costs with patients: an opportunity for empathic communication.

Authors:  James T Hardee; Frederic W Platt; Ilene K Kasper
Journal:  J Gen Intern Med       Date:  2005-07       Impact factor: 5.128

2.  Rationing in the intensive care unit.

Authors:  Robert D Truog; Dan W Brock; Deborah J Cook; Marion Danis; John M Luce; Gordon D Rubenfeld; Mitchell M Levy
Journal:  Crit Care Med       Date:  2006-04       Impact factor: 7.598

3.  Specialty distribution of U.S. physicians--the invisible driver of health care costs.

Authors:  S A Schroeder; L G Sandy
Journal:  N Engl J Med       Date:  1993-04-01       Impact factor: 91.245

4.  Advance care planning as a process: structuring the discussions in practice.

Authors:  L L Emanuel; M Danis; R A Pearlman; P A Singer
Journal:  J Am Geriatr Soc       Date:  1995-04       Impact factor: 5.562

5.  Reducing health care costs by reducing the need and demand for medical services. The Health Project Consortium.

Authors:  J F Fries; C E Koop; C E Beadle; P P Cooper; M J England; R F Greaves; J J Sokolov; D Wright
Journal:  N Engl J Med       Date:  1993-07-29       Impact factor: 91.245

6.  Family perceptions of prognosis, silence, and the "suddenness" of death.

Authors:  Ann J Russ; Sharon R Kaufman
Journal:  Cult Med Psychiatry       Date:  2005-03

7.  Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults.

Authors:  P M Lantz; J S House; J M Lepkowski; D R Williams; R P Mero; J Chen
Journal:  JAMA       Date:  1998-06-03       Impact factor: 56.272

8.  The impact of serious illness on patients' families. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment.

Authors:  K E Covinsky; L Goldman; E F Cook; R Oye; N Desbiens; D Reding; W Fulkerson; A F Connors; J Lynn; R S Phillips
Journal:  JAMA       Date:  1994-12-21       Impact factor: 56.272

9.  The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatments.

Authors:  W A Knaus; F E Harrell; J Lynn; L Goldman; R S Phillips; A F Connors; N V Dawson; W J Fulkerson; R M Califf; N Desbiens; P Layde; R K Oye; P E Bellamy; R B Hakim; D P Wagner
Journal:  Ann Intern Med       Date:  1995-02-01       Impact factor: 25.391

10.  Stability of choices about life-sustaining treatments.

Authors:  M Danis; J Garrett; R Harris; D L Patrick
Journal:  Ann Intern Med       Date:  1994-04-01       Impact factor: 25.391

View more
  5 in total

1.  Exploring public attitudes towards approaches to discussing costs in the clinical encounter.

Authors:  Marion Danis; Roseanna Sommers; Jean Logan; Beverly Weidmer; Shirley Chen; Susan Goold; Steven Pearson; Greer Donley; Elizabeth McGlynn
Journal:  J Gen Intern Med       Date:  2013-07-24       Impact factor: 5.128

2.  "It's a mess sometimes": patient perspectives on provider responses to healthcare costs, and how informatics interventions can help support cost-sensitive care decisions.

Authors:  Olivia K Richards; Bradley E Iott; Tammy R Toscos; Jessica A Pater; Shauna R Wagner; Tiffany C Veinot
Journal:  J Am Med Inform Assoc       Date:  2022-05-11       Impact factor: 7.942

3.  Financial hardship and the intensity of medical care received near death.

Authors:  Reginald D Tucker-Seeley; Gregory A Abel; Hajime Uno; Holly Prigerson
Journal:  Psychooncology       Date:  2014-07-23       Impact factor: 3.894

4.  Financial risk protection at the bedside: How Ethiopian physicians try to minimize out-of-pocket health expenditures.

Authors:  Ingrid Miljeteig; Frehiwot Berhane Defaye; Paul Wakim; Dawit Neema Desalegn; Yemane Berhane; Ole Frithjof Norheim; Marion Danis
Journal:  PLoS One       Date:  2019-02-12       Impact factor: 3.240

5.  Advance directives completion and hospital out-of-pocket expenditures.

Authors:  Yujun Zhu; Susan Enguidanos
Journal:  J Hosp Med       Date:  2022-05-08       Impact factor: 2.899

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.